Food and Drug Administration (FDA) Wegovy (semaglutide) Clinical Trial Data (showing dose-dependent weight loss): Centers for Disease Control and Prevention (CDC) Rethinking Weight Loss: National Library of Medicine Body Composition Changes in Weight Loss:
July 1, 2026 Additional Live Streams Top Stories Top Stories Urgent search for suspect after deadly shooting near Seattle's Space Needle 4 hours ago Powerful tornado slams Wisconsin neighborhood 4 hours ago Pres
By reducing appetite, promoting feelings of fullness, and improving blood sugar control, GLP-1 medications can lead to significant weight loss in individuals with obesity or overweight conditions
Some people who struggled with semaglutide actually do better on tirzepatide, and vice versa
Understanding the complex relationship between this medication, weight loss, metabolic health, and sexual function helps patients and clinicians navigate these concerns
The hormone is released after meals and activates the GLP-1 receptor in the brain and pancreas
